Johnson & Johnson vs Nirvana Life Sciences Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $4 M for Nirvana Life Sciences Inc., 163119 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Dec 25, 2022 for Nirvana Life Sciences Inc.). Nirvana Life Sciences Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.
Market cap history
● Johnson & Johnson● Nirvana Life Sciences Inc.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Johnson & Johnson JNJ · #23 in the world | Nirvana Life Sciences Inc. NIRV.CN |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇨🇦 Canada |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 1886 | — |
| Size | ||
| Market cap | $652.5 B | $4 M* |
| Revenue | $94.2 B | — |
| Net income | $26.8 B | — |
| Employees | 138,200 | — |
| Valuation | ||
| P/E ratio | 40.5× | — |
| Price to sales | 6.6× | — |
| Price to book | 8.0× | — |
| Free cash flow yield | 3.0% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026 | Market cap Dec 2022 |
Questions and answers#
Which is bigger, Johnson & Johnson or Nirvana Life Sciences Inc.?
Johnson & Johnson is the larger company by market value: $652.5 B against $4 M for Nirvana Life Sciences Inc., 163119 times as much (market caps of Oct 29, 2026 for Johnson & Johnson and Dec 25, 2022 for Nirvana Life Sciences Inc.). Nirvana Life Sciences Inc.'s value is the last on file, from Dec 25, 2022: no market-data feed is connected for its exchange yet.